fullerene c60 has been researched along with tetradecanoylphorbol acetate in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dellinger, A; Kepley, CL; Lenk, R; MacFarland, D; Zhou, Z | 1 |
1 other study(ies) available for fullerene c60 and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Fullerene nanomaterials inhibit phorbol myristate acetate-induced inflammation.
Topics: Animals; Dermatitis, Contact; Ear Auricle; Edema; Fullerenes; Inflammation; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Molecular Structure; Nanostructures; Tetradecanoylphorbol Acetate | 2009 |